Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Iain M. Cockburn

A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.

scientific article

Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA

scientific article published on 01 January 2003

Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases

scientific article

Characteristics of demand for pharmaceutical products: an examination of four cephalosporins

scientific article published on 01 January 1997

Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine

scientific article published on 01 May 1999

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

scientific article

Loss of work productivity due to illness and medical treatment

scientific article

Mixed Poisson regression models with covariate dependent rates

scientific article published in June 1996

National trends in asthma visits and asthma pharmacotherapy, 1978-2002.

scientific article published in April 2003

Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research

scientific article published in November 2001

Scale, scope, and spillovers: the determinants of research productivity in drug discovery

scientific article published on 01 January 1996

The changing structure of the pharmaceutical industry

scientific article published on 01 January 2004

The hidden cost of low prices: limited access to new drugs in India

scientific article published in September 2014

The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications

scientific article published on 01 December 2006

The market for follow-on biologics: how will it evolve?

scientific article published on September 2006

Why are some regions more innovative than others? The role of small firms in the presence of large labs